The last we heard from Impax Laboratories was in late 2009 when they had filed an Abbreviated New Drug Application (ANDA 91-447) to produce a generic version of Oracea. …
oracea articles ↓
Galderma blocking Impax making Generic Oracea
June 13th, 2011, by David Pascoe | oracea
LA Clinic looking for Oracea Biomarkers Study Participants
April 28th, 2011, by David Pascoe | clinical trials, oracea
The Vitligo and Pigmentation Institute of Southern California is hosting part of the trial to evaluate Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea vs Placebo. This trial is looking to prove changes in inflammatory markers like the peptide LL-37 and the MMP family match the improvement seen when taking Oracea. The trial is scheduled to involve 170 participants at …
Generic Oracea Legal Trial now in July 2011
April 12th, 2011, by David Pascoe | oracea
I have been watching for a while to see for any developments in the legal proceedings between Mylan and Galderma. These proceedings will determine whether Mylan is allowed to sell Generic Oracea. This is of interest to many rosacea sufferers who consider that Oracea is too …
Galderma, with Oracea looking for Inflammatory Pathway Markers
March 9th, 2011, by David Pascoe | galderma, oracea, rosacea cause
Seemingly wanting to help answer the question How do tetracyclines help Rosacea? Galderma has announced a large trial to measure the changes in inflammatory pathway markers when you take Oracea.
Whilst the trial only directly mentions LL-37 and MMP I would expect other well known markers to be measured as well.
If the researchers include markers that can be proven to be indicative of rosacea disease, …
Cutis posts Oracea Phase 4 (ORCA) papers for free online
January 18th, 2011, by David Pascoe | doxycycline, galderma, oracea
Late last year Galderma generated quite a lot of publicity in the lead up to the release of the Phase 4 trials of Oracea. Phase IV trials typically …
